Table 3.

Analyses of secondary outcomes for PBK/TOPK protein in tumors.

Secondary outcomes	No. of data set	No. of cases	Pooled HR (95% CI)	p-value	Model	Phet	I2 (%)
RFS 12, 20 ,28	3	621	1.63 (1.02-2.24)	<0.001	Fixed	0.490	0.0
DFS 18, 22, 24, 29	4	1010	1.69 (1.16-2.23)	<0.001	Fixed	0.677	0.0
PFS 13, 16	2	195	2.56 (0.80-4.32)	NS	Fixed	0.594	0.0